Form 4 for MREO Mereo BioPharma Group plc
Accepted 2024-08-23 00:00:00 ET · period of report 2024-08-22 · accession 0000950170-24-100281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-23 | 2024-08-22 | MREO | PAKIANATHAN DEEPIKA | Dir | M - OptEx | $1.44 | +105.2K | 1,825 | New | +$151.1K |
| D | 2024-08-23 | 2024-08-22 | MREO | PAKIANATHAN DEEPIKA | Dir | S - Sale+OE | $4.43 | -105.2K | 0 | -100% | -$466.2K |
| DM | 2024-08-23 | 2024-08-22 | MREO | PAKIANATHAN DEEPIKA | Dir | M - OptEx | $0.00 | -173.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2024-08-22 | M | A | 43,485 | $0.94 | 103,173 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer. |
| 2 | Common | American Depositary Shares representing Ordinary Shares | 2024-08-22 | M | A | 2,071 | $3.87 | 105,244 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer. |
| 3 | Common | American Depositary Shares representing Ordinary Shares | 2024-08-22 | M | A | 12,418 | $2.72 | 20,735 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer. |
| 4 | Common | American Depositary Shares representing Ordinary Shares | 2024-08-22 | M | A | 38,953 | $1.31 | 59,688 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer. |
| 5 | Common | American Depositary Shares representing Ordinary Shares | 2024-08-22 | M | A | 6,492 | $1.84 | 8,317 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer. |
| 6 | Common | American Depositary Shares representing Ordinary Shares | 2024-08-22 | S | D | 105,244 | $4.43 | 0 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer. (F2) Sale is due to fund administration reasons. (F3) The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.360 to $4.495, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc ("Mereo"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnote (3) to this Form |
| 7 | Common | American Depositary Shares representing Ordinary Shares | 2024-08-22 | M | A | 1,825 | $3.00 | 1,825 | D | — | — | (F1) Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer. |
| 8 | Derivative | Share Options (right to buy) | 2024-08-22 | M | D | 55,000 | $0.00 | 0 | D | $0.94 · — to 2033-02-01 | 55,000 American Depository Shares | (F8) Vested in substantially equal monthly installments over a one year period from the February 1, 2023 grant date. |
| 9 | Derivative | Share Options (right to buy) | 2024-08-22 | M | D | 15,000 | $0.00 | 30,000 | D | $3.87 · — to 2034-02-08 | 15,000 American Depository Shares | (F9) Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date. As of June 8, 2024, 15,000 Share Options have vested. |
| 10 | Derivative | Share Options (right to buy) | 2024-08-22 | M | D | 55,000 | $0.00 | 0 | D | $1.31 · — to 2032-02-01 | 55,000 American Depository Shares | (F7) Vested in substantially equal monthly installments over a one year period from the February 1, 2022 grant date. |
| 11 | Derivative | Share Options (right to buy) | 2024-08-22 | M | D | 31,500 | $0.00 | 0 | D | $2.72 · — to 2031-02-01 | 31,500 American Depository Shares | (F6) Vested in substantially equal monthly installments over a one year period from the February 1, 2021 grant date. |
| 12 | Derivative | Share Options (right to buy) | 2024-08-22 | M | D | 5,500 | $0.00 | 0 | D | $3.00 · — to 2029-07-23 | 5,500 American Depository Shares | (F4) Vested in substantially equal monthly installments over a one year period from the July 23, 2019 grant date. |
| 13 | Derivative | Share Options (right to buy) | 2024-08-22 | M | D | 11,000 | $0.00 | 0 | D | $1.84 · — to 2030-02-20 | 11,000 American Depository Shares | (F5) Vested in substantially equal monthly installments over a one year period from the February 20, 2020 grant date. |